Mei Pharma, Common Stock Debt To Equity
| LITS Stock | 2.09 0.14 7.18% |
Fundamental analysis of MEI Pharma, allows traders to better anticipate movements in MEI Pharma,'s stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| Debt To Equity | 0.47 | 0.28 |
MEI | Debt To Equity | Build AI portfolio with MEI Stock |
MEI Pharma, Common Company Debt To Equity Analysis
MEI Pharma,'s Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current MEI Pharma, Debt To Equity | 0.28 |
Most of MEI Pharma,'s fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MEI Pharma, Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
MEI Debt To Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for MEI Pharma, is extremely important. It helps to project a fair market value of MEI Stock properly, considering its historical fundamentals such as Debt To Equity. Since MEI Pharma,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MEI Pharma,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MEI Pharma,'s interrelated accounts and indicators.
Click cells to compare fundamentals
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
MEI Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MEI Pharma,'s direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MEI Pharma, could also be used in its relative valuation, which is a method of valuing MEI Pharma, by comparing valuation metrics of similar companies.MEI Pharma, is currently under evaluation in debt to equity category among its peers.
MEI Fundamentals
| EBITDA | (17.09 M) | |||
| Net Income | (15.95 M) | |||
| Total Debt | 1.35 M | |||
| Cash Flow From Operations | (20.84 M) | |||
| Total Asset | 18.29 M | |||
| Retained Earnings | (404.16 M) | |||
| Working Capital | 16.93 M | |||
| Net Asset | 18.29 M |
About MEI Pharma, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MEI Pharma, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MEI Pharma, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MEI Pharma, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MEI Stock Analysis
When running MEI Pharma,'s price analysis, check to measure MEI Pharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma, is operating at the current time. Most of MEI Pharma,'s value examination focuses on studying past and present price action to predict the probability of MEI Pharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma,'s price. Additionally, you may evaluate how the addition of MEI Pharma, to your portfolios can decrease your overall portfolio volatility.